Lupus Nephritis

Lupus Nephritis; Here study present today at the Annual European Congress of Rheumatology (EULAR 2019) suggest maintenance therapy with cyclosporine (CYA) which results in more rapid remission of proteinuria compare to mycophenolate mofetil (MMF) or azathioprine (AZA) in patients with lupus nephritis. The efficacy of CYA, MMF and AZA in obtaining and maintaining remission of lupus nephritis (LN) is comparable over the long term.

Drugs as maintenance therapy

Study is the first to compare these three drugs as maintenance therapy in the long term; so said Lorenza Maria Argolini, Rheumatology Consultant of the Lupus Clinic, ASST Pini CTO, Milan, Italy. Of interest are the results achieve in the CYA group where, despite worse clinical conditions at the beginning of maintenance therapy; so they observe a rapid achievement of remission in the great majority of patients.

The study follow 104 patients with lupus nephritis over 10 years who; hence after six months of induction therapy, receive maintenance therapy of either CYA, MMF or AZA (32, 36, and 36 patients respectively). At the beginning of maintenance therapy complete, partial and no response rates were 28.2%, 59.3%, and 12.5% in CYA, 50%, 44.5% and 5.5% in MMF and 38.8%, 55.2% and 6% in AZA group.

At one year, after six months of maintenance therapy; so in CYA the percentage of patients in complete remission increase to 72% (vs. 64% in MMF and 44.2% in AZA), at five years it was 81.5% (vs. 86% in AZA and 81% in MMF) and 84.5% at 10 years vs. 72% in MMF and 70% in AZA.

Lupus nephritis is inflammation

Lupus nephritis is a serious condition requiring early aggressive therapy to achieve remission; however, the type and duration of immuno suppression after achieving response remain a matter of controversy; hence said Professor John D. Isaacs, Chairperson of the Abstract Selection Committee, EULAR. It is great to see these long term data; which will help further our understanding in this complex area.

Lupus nephritis is inflammation or swelling in the kidneys that stops them working properly. It is a serious complication of systemic lupus erythematosus (SLE); an autoimmune disease that can affect different organs and parts of the body. Treatment often consists of a period of intensive immuno suppressive therapy (induction therapy); so follow by a longer period of less intensive maintenance therapy.

This multi-centre retrospective observational study include patients with SLE; also biopsy prove lupus nephritis who enter the study either at diagnosis or during a flare. At induction there were no significant differences between the three groups; so in histological classes at renal biopsy, mean serum creatinine, eGFR and proteinuria, and type of induction therapy. Renal response was measure at one, five; also 10 years and recorde as total response (eGFR>60ml/min and proteinuria <0.5g/die), partial response (eGFR>60ml/min and proteinuria >0.5g/die), or no response (eGFR<60ml/min).